Yang, C., Jia, Q., Zhao, C., Wei, H., Liu, T., Yang, X., Jiao, J., Wu, Z., Zhao, J., Zhou, W., Ma, X., Lou, Y., Zhang, E., Xing, J., Zhang, H., Xiao, J. (2025). Camrelizumab plus apatinib in patients with advanced or refractory chordoma: A single-arm, open-label, phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11503